NasdaqGM - Delayed Quote USD

Loncar China BioPharma ETF (CHNA)

13.53 -0.01 (-0.07%)
At close: October 17 at 3:51 PM EDT

Performance Overview: CHNA

Trailing returns as of 10/27/2023. Category is China Region.

YTD Return

CHNA
0.29%
Category
3.05%

1-Year Return

CHNA
27.28%
Category
18.48%

3-Year Return

CHNA
10.97%
Category
17.29%

Trailing Returns (%) Vs. Benchmarks

Monthly Total Returns
CHNA
Category
YTD
0.29%
-3.05%
1-Month
27.45%
0.09%
3-Month
14.50%
-3.05%
1-Year
27.28%
-18.48%
3-Year
-10.97%
-17.29%
5-Year
2.04%
-3.30%
10-Year
0.00%
1.68%
Last Bull Market
0.00%
0.00%
Last Bear Market
0.00%
0.00%

Annual Total Return (%) History

Year
CHNA
Category
2022
-29.85%
-25.16%
2021
-7.97%
-7.44%
2020
31.93%
37.10%
2019
29.48%
25.86%

ETF Summary

The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.

ETF Overview

Category China Region
Fund Family Loncar Investments
Net Assets --
YTD Daily Total Return 0.29%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers